- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Medical Equipment/Devices
- Sub-Industry: Life Science Equipment
GenMark Diagnostics Inc
+ Add to WatchlistGNMK:US
9.5700 USD 1.4000 12.76%As of 16:30:00 ET on 06/18/2013.
Snapshot for GenMark Diagnostics Inc (GNMK)
| Open: | 10.4500 | Day's Range: | 9.5100 - 10.6800 | Volume: | 1,863,194 |
|---|---|---|---|---|---|
| Previous Close: | 10.9700 | 52wk Range: | 4.0200 - 15.9980 | 1-Yr Rtn: | +114.57% |
Key Statistics for GNMK
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | - |
| Est. EPS (USD) (12/2013) | -0.8050 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 313.61 |
| Shares Outstanding (M) | 32.77 |
| 30 Day Average Volume | 347,048 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/07/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for GNMK
Company Profile & Key Executives for GNMK
GenMark Diagnostics Inc. is a molecular diagnostics company focused on developing and commercializing its biomarker detection technology. The Company's system supports a broad range of molecular diagnostic tests with a compact workstation and self-contained, disposable test cartridges.
| Hany MassaranyPresident/CEO | Richard B SlanskyChief Financial Officer |
| Matthew Robert CohenSenior VP/General Counsel/Secy | Jennifer Anne WilliamsSenior VP:Global Operations |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
GNMK News
-
Industry News
No stories found
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page